PharmaCyte Biotech
Quarterly Financials
| Values in thousands | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,268 | -1,868 | -1,409 | |
EBIT | 117 | -1,870 | 1,896 | |
Net Income | 23,421 | 1,346 | -619 | 2,789 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -373 | -332 | -177 | -1,984 |
Cash | 32,635 | 50,179 | 61,210 | 73,425 |
Basic Shares | 7,866 | 8,037 | 8,606 | 8,765 |
Annual Financials
| Values in thousands | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | 333 | -4,315 | -4,238 | -3,624 |
EBIT | -6,186 | -10,771 | -8,630 | -7,247 |
Net Income | 333 | -4,315 | -4,085 | -3,554 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,151 | -3,793 | -4,117 | -3,330 |
Cash | 50,179 | 68,039 | 85,400 | 2,202 |
Basic Shares | 9,581 | 19,489 | 15,521 | 1,678,572 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-07-31 | $1.90 |
2024-04-30 | -$0.31 |
2024-01-31 | -$0.07 |
2023-10-31 | -$0.25 |
